BMY Bristol-Myers Squibb
Stock · NYSE · United States · Healthcare · US1101221083
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Bristol-Myers Squibb, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
62.73 USD
-0.63%
52-week range
45.27 – 68.64
Dividend yield3.99%
Market cap129.0B
NowoTrade score
70 Grade A
Price history
Daily prices in USD.
Updated 06 Nov 2026 18:04. Information, not advice.
Results
Next results
04 Feb 2027
in 90 days · 08:00 · estimate 1.50
Last results
1.35 vs 1.17 estimated
29 Oct 2026 · Beat +15.2%
Beat the estimate
11 of 12
0 missed · 1 in line · 10 beats in a row
Average surprise
+15.6%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.50 | — | — | Upcoming |
| 29 Oct 2026 07:00 | 1.17 | 1.35 | +15.2% | Beat |
| 30 Jul 2026 07:00 | 1.60 | 2.04 | +27.7% | Beat |
| 30 Apr 2026 07:00 | 1.42 | 1.58 | +11.2% | Beat |
| 05 Feb 2026 07:00 | 1.20 | 1.26 | +4.6% | Beat |
| 30 Oct 2025 07:00 | 1.52 | 1.63 | +7.6% | Beat |
| 31 Jul 2025 07:00 | 1.10 | 1.46 | +32.6% | Beat |
| 24 Apr 2025 07:00 | 1.50 | 1.80 | +19.9% | Beat |
| 06 Feb 2025 06:00 | 1.47 | 1.67 | +13.8% | Beat |
| 31 Oct 2024 06:00 | 1.50 | 1.80 | +20.0% | Beat |
| 26 Jul 2024 06:00 | 1.63 | 2.07 | +27.4% | Beat |
| 25 Apr 2024 06:00 | -4.40 | -4.40 | -0.1% | In line |
| 02 Feb 2024 06:00 | 1.58 | 1.70 | +7.8% | Beat |
| 26 Oct 2023 06:00 | 1.77 | 2.00 | +13.0% | Beat |
| 27 Jul 2023 07:00 | 1.99 | 1.75 | -12.0% | Miss |
| 27 Apr 2023 06:00 | 1.97 | 2.05 | +3.9% | Beat |
| 02 Feb 2023 06:00 | 1.73 | 1.82 | +5.2% | Beat |
| 25 Oct 2022 19:00 | 1.83 | 1.99 | +8.5% | Beat |
| 27 Jul 2022 06:00 | 1.80 | 1.93 | +7.3% | Beat |
| 29 Apr 2022 06:00 | 1.90 | 1.96 | +3.3% | Beat |
| 04 Feb 2022 06:00 | 1.80 | 1.83 | +1.7% | Beat |
| 27 Oct 2021 06:00 | 1.92 | 2.00 | +4.3% | Beat |
| 28 Jul 2021 06:00 | 1.90 | 1.93 | +1.8% | Beat |
| 29 Apr 2021 06:00 | 1.81 | 1.74 | -3.9% | Miss |
| 04 Feb 2021 06:00 | 1.42 | 1.46 | +3.1% | Beat |
Annual results
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 48.2B | -0.2% | 7.1B | 14.6% | 3.46 | +178.5% | 12.8B |
| 2024 | 48.3B | +7.3% | -8.9B | -18.5% | -4.41 | -214.2% | 13.9B |
| 2023 | 45B | -2.5% | 8B | 17.8% | 3.86 | +30.8% | 12.7B |
| 2022 | 46.2B | — | 6.3B | 13.7% | 2.95 | — | 11.9B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 15 Dec 2023 | 51.16 | 51.45 | 50.69 | 50.89 | -1.13% | 44,147,600 | |
| 14 Dec 2023 | 52.46 | 52.54 | 51.00 | 51.47 | -0.75% | 20,212,600 | |
| 13 Dec 2023 | 50.07 | 51.86 | 49.94 | 51.86 | +2.67% | 15,557,000 | |
| 12 Dec 2023 | 50.80 | 50.94 | 49.80 | 50.51 | -1.14% | 14,215,500 | |
| 11 Dec 2023 | 50.52 | 51.14 | 50.27 | 51.09 | +1.55% | 18,432,900 | |
| 08 Dec 2023 | 50.26 | 50.54 | 50.09 | 50.31 | +0.30% | 10,123,100 | |
| 07 Dec 2023 | 50.30 | 51.00 | 49.99 | 50.16 | +0.56% | 14,710,600 | |
| 06 Dec 2023 | 50.32 | 50.43 | 49.78 | 49.88 | -0.70% | 13,839,800 | |
| 05 Dec 2023 | 49.80 | 50.40 | 49.56 | 50.23 | +0.50% | 12,659,500 | |
| 04 Dec 2023 | 49.96 | 50.76 | 49.77 | 49.98 | -0.24% | 14,238,600 | |
| 01 Dec 2023 | 49.40 | 50.18 | 48.93 | 50.10 | +1.46% | 12,806,400 | |
| 30 Nov 2023 | 48.78 | 49.40 | 48.25 | 49.38 | +1.35% | 17,044,300 | |
| 29 Nov 2023 | 49.06 | 49.35 | 48.67 | 48.72 | -0.41% | 12,653,100 | |
| 28 Nov 2023 | 49.05 | 49.32 | 48.82 | 48.92 | -0.20% | 11,372,800 | |
| 27 Nov 2023 | 49.61 | 49.72 | 48.82 | 49.02 | -1.49% | 17,681,600 | |
| 24 Nov 2023 | 49.75 | 49.91 | 49.47 | 49.76 | +0.69% | 5,085,700 | |
| 22 Nov 2023 | 48.75 | 49.50 | 48.56 | 49.42 | +1.94% | 14,734,800 | |
| 21 Nov 2023 | 48.83 | 49.04 | 48.45 | 48.48 | -0.86% | 14,669,600 | |
| 20 Nov 2023 | 48.78 | 50.17 | 48.42 | 48.90 | -3.82% | 27,943,500 | |
| 17 Nov 2023 | 51.19 | 51.22 | 50.60 | 50.84 | 0.00% | 10,229,500 | |
| 16 Nov 2023 | 51.46 | 51.74 | 50.25 | 50.84 | -1.42% | 14,458,500 | |
| 15 Nov 2023 | 50.27 | 51.63 | 50.15 | 51.57 | +2.08% | 13,407,600 | |
| 14 Nov 2023 | 50.45 | 51.18 | 50.26 | 50.52 | +0.74% | 12,025,300 | |
| 13 Nov 2023 | 50.45 | 50.67 | 50.06 | 50.15 | -0.91% | 12,047,100 | |
| 10 Nov 2023 | 50.61 | 50.70 | 49.58 | 50.61 | +0.40% | 12,697,600 |
Page 30 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
Key data
- Previous close
- 63.13 USD
- Market cap
- 129.0B
- Dividend yield
- 3.99%
- 5-year average yield
- 3.86%
- Payout ratio
- 56%
- Last dividend
- 0.6300 USD · 02 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Oct 2026 | 0.6300 USD |
| 02 Jul 2026 | 0.6300 USD |
| 02 Apr 2026 | 0.6300 USD |
| 02 Jan 2026 | 0.6300 USD |
| 03 Oct 2025 | 0.6200 USD |
| 03 Jul 2025 | 0.6200 USD |
| 04 Apr 2025 | 0.6200 USD |
| 03 Jan 2025 | 0.6200 USD |
| 04 Oct 2024 | 0.6000 USD |
| 05 Jul 2024 | 0.6000 USD |
| 04 Apr 2024 | 0.6000 USD |
| 04 Jan 2024 | 0.6000 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 16.6 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 23.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 7.4 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 9.1 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.3 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 14.07× | Good | 32.71× |
| P/E (forward) | 9.54× | Good | 15.76× |
| Price / book | 5.54× | Weak | 3.74× |
| Price / sales | 2.59× | Fair | 3.52× |
| EV / EBITDA | 8.96× | Good | 13.54× |
| Free cash flow yield | 4.9% | Fair | 3% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 70.5% | Good | 66.1% |
| Operating margin | 33.8% | Good | 8% |
| Net margin | 18.5% | Good | 3.5% |
| Return on equity | 44% | Good | 6.4% |
| Return on assets | 10.9% | Good | 3.9% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 1.4% | Weak | 10.5% |
| EPS growth / year | 5.5% | Fair | 7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.91× | Weak | 0.52× |
| Net debt / EBITDA | 1.77× | Fair | 1.62× |
| Interest cover | 7.26× | Fair | 3.3× |
| Current ratio | 1.59× | Good | 2.12× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 55.9% | Fair | 0% |
| Payout of free cash flow | 79.3% | Weak | 45% |
| Payout of free cash flow (3 years) | 37.2% | Good | — |
| Dividend growth / year | 4.7% | Fair | 7.1% |
| Years of rising dividends | 4 | Fair | 4.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow BMY and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.